Promise: “Double the number of drive-through testing sites, invest in next-generation testing, including at home tests and instant tests, so we can scale up our testing capacity by orders of magnitude.”
Before vaccinations were widely available, covid-19 tests were considered one of the few tools to help control the spread of the coronavirus.
That’s why then-candidate Joe Biden promised during the 2020 presidential campaign to boost the United States’ testing capacity as one way he would “beat covid-19.”
Specifically, Biden’s campaign website promised that, if elected, he would “double the number of drive-through testing sites” and “invest in next-generation testing, including at-home tests and instant tests, so we can scale up our testing capacity by orders of magnitude.”
KHN has teamed up with our partners at PolitiFact to analyze Biden’s promises during the 2020 presidential campaign. Now that Biden has been president almost five months, we checked how he has done on this one. Experts say testing capacity has improved. At the same time, testing demand has decreased and part of Biden’s promise — doubling the number of drive-thru testing sites — is harder to pin down.
In February, about a month after Biden took office, his administration announced at a news briefing that it would invest more than $1.6 billion in covid testing. These funds would, among other things, expand testing in schools and other congregate settings, increase domestic manufacturing of testing supplies, and help track covid variants via genetic sequencing.
Then, Biden’s American Rescue Plan, which successfully passed through both chambers of Congress in March, also allocated funds specifically to expand testing.
On March 17, the Department of Health and Human Services announced that $10 billion from that legislation would be devoted to screening and testing so schools could reopen, and $2.25 billion to scaling up testing in underserved populations as well as providing new guidance. An additional $4.8 billion was allotted in May to reimburse health care providers for testing uninsured people for the coronavirus.
Dr. Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials, the organization representing state public health agencies, said states have begun to receive their American Rescue Plan funds and are starting to plan how testing will be implemented to help schools conduct classes in person in the fall.
But whether Biden was successful in doubling the number of drive-thru testing sites is unclear. KHN and PolitiFact asked various testing experts for their take, and they generally said they weren’t aware of any data that showed the number of sites had doubled. Some hypothesized, though, that this may have been because many public health resources were shifted away from testing sites to staff and to set up vaccination sites once covid vaccines became available to the public.
“I think states did shift their efforts to vaccination, because that was the move in the spring,” said Plescia. But as more people were vaccinated, demand dropped, and “if we had those drive-thru testing sites we ended up closing them,” he added. “It was a promise we ended up not needing to keep.”
Indeed, there have been reports of shuttered testing sites across the U.S. In Florida all 27 state-run testing sites closed at the end of May. Oklahoma also recently closed a mass testing site once demand fell to fewer than 50 tests a day and, in late May, New Jersey closed the state’s first outdoor testing site.
The Johns Hopkins University Testing Tracker shows that testing demand in the U.S. has significantly dropped. In January, about 2 million tests were conducted in a day. In May, that number dropped to about 850,000. This reduction has occurred at the same time the number of Americans getting vaccinated is rising and covid cases and deaths are dropping.
The Centers for Disease Control and Prevention also recently recommended that vaccinated people who have been exposed to someone with covid no longer need to be tested if asymptomatic, and that vaccinated people can be excluded from workplace testing in most instances.
Still, Plescia thinks that if future outbreaks occur in certain areas and more tests are required, states would be able to scale up to meet the need. Especially because of the increased availability of at-home tests — another Biden focus.
So far, the administration has contracted with several private companies to ensure the production and distribution of both rapid and at-home covid tests.
Ellume, an Australian diagnostics company, was the first to receive an emergency use authorization from the Food and Drug Administration for an at-home test. In February, the Department of Defense announced it had awarded Ellume almost $232 million to build a U.S. factory and increase home-test production. The contract also includes the allocation of 8.5 million home tests to the federal government, which must be provided by the end of 2021.
Abbott, another diagnostics company, received significant funds from the federal government for tests during both the Biden and Trump administrations. In March, HHS announced that Abbott had received a contract to deliver 50 million of its rapid point-of-care tests to long-term care facilities.
Currently, five over-the-counter at-home tests have been authorized for emergency use by the FDA. In addition to the Ellume and Abbott tests, which provide results at home in 15 minutes, a Labcorp test is also available over the counter, but its results take one or two days to return.
The increase in supply and decrease in demand could mean some testing efforts originally envisioned by the Biden administration might not be rolled out and the U.S. might never get to “orders-of-magnitude” increases in testing, Josh Michaud, associate director of global health policy at KFF, wrote in an email.
Overall, though, despite the number of drive-thru or mass-testing sites closed down, there is now a greater availability of covid tests. The Biden administration has also provided significant funding toward testing, even if some of it has been redirected.
“In general, I think testing is much better,” Jeffrey Schlegelmilch, director of the Columbia University National Center for Disaster Preparedness, wrote in an email. “There are easier-to-access options, and the wait times seem to be much faster for results. … There are also more resources available to state and local health departments to perform testing. So I would qualify this as a promise kept.”
So would we. We rate this a Promise Kept.
The Associated Press, “OU Health Closing Public Coronavirus Testing as Demand Drops,” May 27, 2021
Bradenton Herald, “State-Run COVID Testing Sites Closing by May 28. Manatee, Sarasota Sites to Close Saturday,” May 12, 2021
Centers for Disease Control and Prevention, “Interim Public Health Recommendations for Fully Vaccinated People,” May 28, 2021
CNBC, “Biden Administration to Invest Over $1.6 Billion to Expand Covid Testing, Sequencing,” Feb. 17, 2021
CVS Health, “Over-the-Counter COVID-19 Testing Now Available at CVS Pharmacy,” April 19, 2021
Department of Defense, “DOD Awards $231.8 Million Contract to Ellume USA LLC to Increase Domestic Production Capacity and Deliver COVID-19 Home Tests,” Feb. 1, 2021
Department of Health and Human Services, “Biden Administration Announces Actions to Expand COVID-19 Testing,” Feb. 17, 2021
Department of Health and Human Services, “Biden Administration to Invest More Than $12 Billion to Expand COVID-19 Testing,” March 17, 2021
Department of Health and Human Services, “HHS to Dedicate $4.8 Billion From American Rescue Plan to COVID-19 Testing for the Uninsured,” May 25, 2021
Email exchange with Aly Morici, director of public affairs at Abbott, June 7, 2021
Email interview with Jeffrey Schlegelmilch, director of the Columbia University National Center for Disaster Preparedness, June 7, 2021
Email interview with Josh Michaud, associate director for global health policy at KFF, June 4, 2021
FierceBiotech.com, “CVS, Walgreens Begin Rolling Out Over-the-Counter COVID Tests From Abbott, Ellume and More,” April 19, 2021
Food and Drug Administration, Coronavirus (COVID-19) Update: June 8, 2021, June 8, 2021
Healthline, “COVID-19 Rapid Tests Now Available at Pharmacies: What to Know,” April 22, 2021
Johns Hopkins University Coronavirus Tracker, Daily State-by-State Testing Trends, accessed June 8, 2021
KHN, “Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You,” April 1, 2021
Patch.com, “COVID-19 Testing Site Closes in Hoboken, After 60,000th Test,” May 21, 2021
Phone interview with Gigi Gronvall, a senior scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, June 8, 2021
Phone interview with Dr. Marcus Plescia, chief medical officer of the Association for State and Territorial Health Officials, June 8, 2021
Phone interview with Dr. Leana Wen, visiting professor of health policy and management at the George Washington University, June 8, 2021
Politico, “Biden Admin Reroutes Billions in Emergency Stockpile, Covid Funds to Border Crunch,” April 15, 2021
The Wayback Machine, JoeBiden.com/covid19/, accessed June 9, 2021
The White House, Press Briefing by White House COVID-19 Response Team and Public Health Officials, Feb. 17, 2021
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).